IART
Income statement / Annual
Last year (2024), Integra LifeSciences Holdings Corporation's total revenue was $1.61 B,
an increase of 4.47% from the previous year.
In 2024, Integra LifeSciences Holdings Corporation's net income was -$6.94 M.
See Integra LifeSciences Holdings Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$1.61 B |
$1.54 B |
$1.56 B |
$1.54 B |
$1.37 B |
$1.52 B |
$1.47 B |
$1.19 B |
$992.08 M |
$882.73 M |
| Cost of Revenue |
$728.47 M
|
$653.18 M
|
$587.36 M
|
$597.81 M
|
$520.83 M
|
$564.68 M
|
$571.50 M
|
$435.51 M
|
$349.09 M
|
$326.54 M
|
| Gross Profit |
$882.06 M
|
$888.39 M
|
$970.31 M
|
$944.64 M
|
$851.03 M
|
$952.88 M
|
$900.95 M
|
$752.73 M
|
$642.99 M
|
$556.19 M
|
| Gross Profit Ratio |
0.55
|
0.58
|
0.62
|
0.61
|
0.62
|
0.63
|
0.61
|
0.63
|
0.65
|
0.63
|
| Research and Development Expenses |
$115.38 M
|
$174.59 M
|
$101.19 M
|
$93.05 M
|
$77.38 M
|
$79.57 M
|
$78.04 M
|
$63.46 M
|
$58.16 M
|
$50.90 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$690.75 M
|
$624.10 M
|
$455.63 M
|
$415.76 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$716.98 M
|
$592.64 M
|
$616.32 M
|
$637.45 M
|
$594.53 M
|
$687.60 M
|
$690.75 M
|
$624.10 M
|
$455.63 M
|
$415.76 M
|
| Other Expenses |
$21.29 M
|
$69.16 M
|
$13.88 M
|
$16.91 M
|
$27.76 M
|
$27.03 M
|
$8.29 M
|
$1.35 M
|
$845,000.00
|
$4.59 M
|
| Operating Expenses |
$853.65 M
|
$836.39 M
|
$731.39 M
|
$747.41 M
|
$699.66 M
|
$794.20 M
|
$789.95 M
|
$707.92 M
|
$527.65 M
|
$476.61 M
|
| Cost And Expenses |
$1.58 B
|
$1.43 B
|
$1.32 B
|
$1.35 B
|
$1.22 B
|
$1.36 B
|
$1.36 B
|
$1.14 B
|
$876.74 M
|
$803.15 M
|
| Interest Income |
$20.04 M
|
$17.20 M
|
$11.92 M
|
$6.74 M
|
$9.30 M
|
$10.78 M
|
$2.80 M
|
$255,000.00
|
$24,000.00
|
$13,000.00
|
| Interest Expense |
$70.63 M
|
$51.38 M
|
$49.59 M
|
$50.40 M
|
$71.58 M
|
$53.96 M
|
$64.68 M
|
$35.02 M
|
$25.80 M
|
$23.52 M
|
| Depreciation & Amortization |
$140.89 M
|
$123.51 M
|
$121.12 M
|
$123.67 M
|
$118.99 M
|
$114.70 M
|
$115.70 M
|
$88.90 M
|
$72.67 M
|
$9.95 M
|
| EBITDA |
$193.29 M |
$274.01 M |
$391.10 M |
$366.33 M |
$267.93 M |
$231.03 M |
$241.04 M |
$135.23 M |
$231.73 M |
$195.59 M |
| EBITDA Ratio |
0.12
|
0.18
|
0.18
|
0.16
|
0.14
|
0.14
|
0.1
|
0.06
|
0.13
|
0.11
|
| Operating Income Ratio |
0.02
|
0.07
|
0.15
|
0.13
|
0.11
|
0.12
|
0.08
|
0.04
|
0.12
|
0.09
|
| Total Other Income/Expenses Net |
-$46.65 M
|
-$30.46 M
|
-$25.03 M
|
$17.45 M
|
-$57.85 M
|
-$33.66 M
|
-$53.60 M
|
-$33.42 M
|
-$24.93 M
|
-$18.92 M
|
| Income Before Tax |
-$18.24 M
|
$81.07 M
|
$213.89 M
|
$214.68 M
|
$93.52 M
|
$60.10 M
|
$57.40 M
|
$11.39 M
|
$90.41 M
|
$60.67 M
|
| Income Before Tax Ratio |
-0.01
|
0.05
|
0.14
|
0.14
|
0.07
|
0.04
|
0.04
|
0.01
|
0.09
|
0.07
|
| Income Tax Expense |
-$11.29 M
|
$13.33 M
|
$33.34 M
|
$45.60 M
|
-$40.37 M
|
$9.90 M
|
-$3.40 M
|
-$53.36 M
|
$15.84 M
|
$53.82 M
|
| Net Income |
-$6.94 M
|
$67.74 M
|
$180.55 M
|
$169.08 M
|
$133.89 M
|
$50.20 M
|
$60.80 M
|
$64.74 M
|
$74.56 M
|
-$3.52 M
|
| Net Income Ratio |
-0
|
0.04
|
0.12
|
0.11
|
0.1
|
0.03
|
0.04
|
0.05
|
0.08
|
-0
|
| EPS |
-0.0902 |
0.87 |
2.18 |
2 |
1.58 |
0.59 |
0.73 |
0.83 |
1 |
-0.0476 |
| EPS Diluted |
-0.0902 |
0.84 |
2.16 |
1.98 |
1.57 |
0.58 |
0.72 |
0.82 |
0.94 |
-0.0476 |
| Weighted Average Shares Out |
$77.01 M
|
$78.17 M
|
$83.00 M
|
$84.70 M
|
$84.65 M
|
$85.64 M
|
$82.86 M
|
$78.39 M
|
$74.72 M
|
$73.88 M
|
| Weighted Average Shares Out Diluted |
$77.01 M
|
$80.34 M
|
$83.52 M
|
$85.49 M
|
$85.23 M
|
$86.49 M
|
$84.45 M
|
$79.12 M
|
$79.19 M
|
$73.88 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
